As compared with WT mice, MMP-13-/- mice exhibited augmented lung fibrosis 28days after bleomycin challenge, as evident from significantly increased collagen staining and hydroxyproline content (Figure 6). The gene discussed is MMP13; the disease is pulmonary fibrosis.